GlassScriptPhysician profile
Grace G Cheng
NPI 1487629572
$9,491.96
in general payments reported to CMS, 2019-2025
53 companies · $2,814 in 2025
The $2,814 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $806 · 2020: $910 · 2021: $1,248 · 2022: $836 · 2023: $1,457 · 2024: $1,420 · 2025: $2,814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,316 · Education: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,316.05 |
| Education | $374.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,953.00 | 2019-2025 | Ubrelvy, Qulipta, Botox |
| Teva Pharmaceuticals USA, INC. | $1,220.46 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Allergan, INC. | $750.72 | 2019-2022 | |
| Lundbeck LLC | $263.41 | 2020-2025 | Vyepti |
| Biogen, INC. | $250.01 | 2020-2025 | Vumerity, Tysabri |
| Axsome Therapeutics, INC. | $231.91 | 2025 | Symbravo |
| Novartis Pharmaceuticals Corporation | $194.80 | 2019-2025 | |
| Genentech USA, INC. | $186.19 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Celgene Corporation | $170.90 | 2021-2025 | Zeposia |
| Csl Behring | $160.45 | 2021-2025 | Hizentra |
| Amgen INC. | $150.40 | 2019-2021 | |
| Lilly USA, LLC | $143.43 | 2019-2025 | Amyvid, Kisunla |
| Medwest Associates | $117.00 | 2021 | |
| Livanova USA, INC. | $114.48 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Eisai INC. | $113.34 | 2023-2025 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.